AL

Implanet SAPAR Implanet Stock Report

Last reporting period 30 Jun, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.016

Micro

Exchange

XPAR - Euronext Paris

ALIMP.PA Stock Analysis

AL

Uncovered

Implanet SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

4/100

Low score

Market cap $B

0.016

Dividend yield

Shares outstanding

31.163 B

Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.

View Section: Eyestock Rating